Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo

J Immunol. 2007 Dec 15;179(12):8051-8. doi: 10.4049/jimmunol.179.12.8051.

Abstract

Receptor for advanced glycation end products (RAGE) is an activation receptor triggered by inflammatory S100/calgranulins and high mobility group box-1 ligands. We have investigated the importance of RAGE on Ag priming of T cells in murine models in vivo. RAGE is inducibly up-regulated during T cell activation. Transfer of RAGE-deficient OT II T cells into OVA-immunized hosts resulted in reduced proliferative responses that were further diminished in RAGE-deficient recipients. Examination of RAGE-deficient dendritic cells did not reveal functional impairment in Ag presentation, maturation, or migratory capacities. However, RAGE-deficient T cells showed markedly impaired proliferative responses in vitro to nominal and alloantigens, in parallel with decreased production of IFN-gamma and IL-2. These data indicate that RAGE expressed on T cells is required for efficient priming of T cells and elucidate critical roles for RAGE engagement during cognate dendritic cell-T cell interactions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigen Presentation*
  • Antigen-Presenting Cells / immunology
  • Cell Movement
  • Dendritic Cells / immunology
  • Lymphocyte Activation
  • Mice
  • Mice, Transgenic
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic / analysis
  • Receptors, Immunologic / genetics
  • Receptors, Immunologic / metabolism*
  • T-Lymphocytes / immunology*
  • Th1 Cells / immunology
  • Toll-Like Receptors / genetics
  • Toll-Like Receptors / metabolism

Substances

  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic
  • Toll-Like Receptors